Reid Gary, Kamarulzaman Adeeba, Sran Sangeeta Kaur
The Centre for Harm Reduction, The Macfarlane Burnet Institute for Medical Research & Public Health, GPO Box 2284, Melbourne 3001, Australia.
Int J Drug Policy. 2007 Mar;18(2):136-40. doi: 10.1016/j.drugpo.2006.12.015. Epub 2007 Jan 29.
In Malaysia the response to illicit drug use has been largely punitive with the current goal of the Malaysian government being to achieve a drug-free society by 2015. This paper outlines the results of a desk-based situation assessment conducted over a 3-week period in 2004. Additional events, examined in 2005, were also included to describe more recent policy developments and examine how these came about. Despite punitive drug policy there has been a substantial rise in the number of drug users in the country. Over two-thirds of HIV/AIDS cases are among injecting drug users (IDUs) and there has been an exponential rise in the number of cases reported. Further, data suggest high risk drug use practices are widespread. Harm reduction initiatives have only recently been introduced in Malaysia. The successful piloting of substitution therapies, in particular methadone and buprenorphine, is cause for genuine hope for the rapid development of such interventions. In 2005 the government announced it will allow methadone maintenance programmes to operate beyond the pilot phase and needle and syringe exchange programmes will be established to serve the needs of IDUs.
在马来西亚,对非法药物使用的应对措施主要是惩罚性的,马来西亚政府目前的目标是到2015年实现无毒品社会。本文概述了2004年为期3周进行的桌面形势评估结果。2005年审查的其他事件也被纳入,以描述最近的政策发展,并研究这些发展是如何产生的。尽管有惩罚性的毒品政策,但该国吸毒者的数量仍大幅上升。超过三分之二的艾滋病毒/艾滋病病例发生在注射吸毒者中,报告的病例数量呈指数级增长。此外,数据表明高风险吸毒行为普遍存在。减少伤害举措直到最近才在马来西亚推出。替代疗法,特别是美沙酮和丁丙诺啡的成功试点,为这类干预措施的迅速发展带来了真正的希望。2005年,政府宣布将允许美沙酮维持治疗方案在试点阶段之后继续实施,并将设立针头和注射器交换方案以满足注射吸毒者的需求。